Haichen Pharmaceuticals: Solid-state battery related business has not yet generated revenue.

Announcement from Haichen Pharmaceutical: The trading price of the company's stock has deviated by more than 30% for three consecutive trading days, indicating abnormal fluctuations in stock trading. The company's layout in the solid-state battery field mainly involves Sichuan Luochen, a joint investment of its holding subsidiary Anqing Huichen and Saikeda Power, which is currently developing adhesive products in a pilot process and has not yet provided samples or formed orders for customers. It is expected to have no significant impact on the company's profits for the current year. The company's recent operations are normal, and there have been no major changes in the internal or external operating environment.